Gergely is a Senior Consultant at Venture Valuation, specializing in biotech valuation for fundraising, licensing, and M&A. He has led over 100 valuation projects for Fortune 500 companies, established biotech firms, and startups, providing strategic insights into value creation. He holds a Pharm.D. from Semmelweis University (Budapest) and an M.Sc. in Bioentrepreneurship from Karolinska Institutet (Stockholm), combining scientific expertise with a business perspective to support investors and innovators.